Lungcast

In this episode, multiple points of view are presented regarding Asthma Exacerbated Respiratory Disease (AERD). Lungcast host Albert Rizzo, MD, was joined by allergist and immunologist Mitchell Grayson, MD, of Nationwide Children’s Hospital, as well as patient advocate Rhonda Nelson and her husband Wayne Nelson of The Little River Band. This discussion delves into the trials and tribulations of diagnosing—and living with—AERD, from disease misconceptions to daily management.

Join the discussion as these guests focus specifically on the role of AI in chest imaging and uncover how these advancements are improving the future of patient care.

Episode Highlights

0:00 Start

1:00 Focus of each guest

2:55 Sampter’s triad and AERD

6:30 Patient experiences with AERD

10:18 Delayed diagnosis and recent changes

11:35 Therapy for AERD

16:32 Resources for patients with asthma

19:01 Day-to-day AERD management

24:14 Importance of keeping a medical journal

27:42 Outro

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

0:15 Intro

1:10 Introducing the Lung Health Cohort Research Study

3:49 The enrollment strategy

7:10 Seeking “the cholesterol of lung disease”

11:50 The role of industry support

14:09 Imaging strategies for long-term lung assessment

17:59 Recruitment challenges

23:05 Final thoughts

26:20 Outro

For our 50th episode, Ravi Kalhan, MD, of Northwestern Medicine, George Washko, MD, of Harvard University, and Amy Olson, MD, Executive Director of Medical Affairs for Boehringer Ingelheim Pharmaceuticals, Inc, join us for a panel discussion around improving patient outcomes through innovative lung health research, such as with the American Lung Association Lung Health Cohort Research Study. 

Tune in to learn more about their collaborative efforts to help identify biomarkers and lifestyle patterns for more accurate identification of disease processes, ideally at onset. 

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

In this episode, Dr. Rachel Eddy of the University of British Columbia explores the evolving field of medical imaging technology and the transformative impact of artificial intelligence. While applications of AI have expanded beyond traditional radiology, it delves into cutting-edge techniques like 3D printing and molecular imaging that are redefining diagnostics and treatment planning.

Join us as we focus specifically on the role of AI in chest imaging and uncover how these advancements are improving the future of patient care.

0:15 Intro

1:10 The history of medical imaging technology

3:02 Artificial intelligence terminology

8:56 Use of AI to assess asthma airway and mucus changes

13:02 Imaging biomarkers for ILD

16:52 Using AI to observe longterm decline of lung function

21:00 Dysanapsis analysis through CT scans

24:04 Xenon-enhanced MRIs for microstructural lung abnormalities

28:50 How will AI us continue to evolve in pulmonology?

31:58 Outro

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

0:16 Intro

2:24 Asthma action plans

3:52 Asthma Peak Week

6:28 School nurse’s role

11:05 SMART inhaler strategy for kids

14:25 Addressing vaping among students

20:18 Discussing vaccines with children and parents

24:01 School air quality issues?

27:50 Final thoughts

29:42 Outro

As families jump into the new school year, this episode brings together Chicago-based allergist and immunologist Dr. Juanita Mora and pediatric pulmonologist Dr. S. Christy Sadreameli of Johns Hopkins Hospital to share their tips for making the return to school as smooth as possible in regard to lung health. 

The lively conversation homes in on asthma control and the phenomenon often referred to as ‘peak week,’ along with the prevalence and hazards of vaping and e-cigarettes affecting the school aged population. Grab your pencils and take notes!

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

0:15 Introduction

2:35 Introducing Janelle Bludorn, MS, PA-C

3:27 Common heat-related illnesses

8:43 How to screen for individual health-related risks

15:27 Respiratory consequences of heat

19:49 The interplay of medicines with heat

26:49 National Weather Service HeatRisk tool

32:58 Behavioral interventions for heat-risk patients

36:27 A FEMA system for heat emergencies?

38:10 Outro

For our July episode, we are visited by Duke University’s Janelle Bludorn, PA-C, MS, for a comprehensive overview of heat-related respiratory illnesses. 

Due to climate change in all regions around the world, extreme heat has become a significant environmental and occupational health hazard with heatstroke classified as a medical emergency. Listen in to better understand the serious risks of exposure to high temperatures.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

0:15 Intro

3:39 Update in pre-lung cancer genome atlas research

17:06 Next steps: applying innovations in bronchoscopy

21:45 When we can anticipate results

25:05 Understanding the lung’s microbiome

29:21 Utility of fragmentomics

31:01 Outro

Dr. Steven Dubinett at University of California, Los Angeles and Dr. Avrum Spira at Boston University revisit our virtual studio to provide an update on their lung cancer interception research, as currently funded by the American Lung Association and LUNGevity Foundation. With the goal of combating cancer at a preliminary stage, Drs. Dubinett and Spira are focused on refining molecular and imaging markers to help identify high-risk premalignant lesions. These findings hope to lead to future therapeutics halting the progression of cells likely to cause invasive cancer.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

0:16 Intro

2:29 Updated community-acquired pneumonia guidelines

5:41 Diagnostic tools for CAP following COVID-19

9:35 Procalcitonin levels as a biomarker

12:30 The CAP treatment algorithm

18:36 Best practices for antibiotic stewardship

20:40 New CAP therapies on the horizon

22:36 ACIP recommendations for vaccination

24:30 Remaining areas of CAP uncertainty

26:30 Final thoughts

27:25 Outro

Featuring infectious disease expert Dr. Thomas File of Summa Health in Ohio, this episode delves into how community-acquired pneumonia has been affected by the COVID-19 pandemic. It additionally covers the role and importance of antibiotic stewardship and the concern of ‘superbugs’ due to antimicrobial resistance.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

0:11 Intro

1:05 Introducing Stephanie Lovinsky-Desir, MD, MS

2:09 Understanding asthma endotypes and phenotypes

5:03 The effect of SMART guideline updates

11:50 Are pulmonary & allergy specialists adopting it?

12:46 The value of biologics in asthma care

18:11 Could they interrupt the atopic march?

19:53 COVID-19 risks in asthma

23:24 Environmental and non-viral illness impacts on asthma

26:11 Research into asthma care inequities

31:47 HFA-containing metered dose inhalers

35:37 Outro

In honor of World Asthma Day, Dr. Stephanie Lovinsky-Desir of Columbia University Irving Medical Center in New York visits our virtual studio to talk about all things asthma. Dr. Lovinsky-Desir, who has a deep understanding of how environmental factors impact children with asthma, touches upon inequities in asthma care, the role of climate change and COVID-19 lessons learned. She also hones in on whether biologic therapies may help interrupt pathways in the atopic march.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

Episode Highlights

0:16 Intro

2:17 What caused the particle pollution spike?

6:28 The health effects of fine particle pollution exposure

10:23 The new EPA particle pollution standard

14:27 Improvements to ozone pollution and the Clean Air Act

18:46 How to advocate for improvement

20:23 Air quality inequity

24:03 Reflecting on 25 years, and looking ahead

25:52 Outro 

Dr. John Balmes, a renowned environmental health sciences expert from the University of California, San Francisco, join Lungcast for a deep dive into the American Lung Association’s newly released 2024 “State of the Air” report. Balmes specifically provides context behind several concerning trends, notably a spike in deadly particle pollution—the highest levels in the past 25 years largely due to wildfires. 

The eye-opening conversation also impresses upon the importance of clean transportation and power generation to help mitigate population-wide risk. 

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

0:16 Intro

2:28 Recent modifications to the lung allocation score

5:11 Monitoring chronic graft rejection

9:23 The rising use of ex vivo lung perfusion 

16:17 The presence of post-COVID patients on the lung transplant waitlist

21:01 Impact of long Covid on transplant rehabilitation

22:51 Double lung transplant in bilateral lung cancer—what’s the future?

26:52 Effect of LAS on lung transplant survival racial disparity

31:05 What lies ahead in the practice of lung transplantation

35:00 Outro

Cleveland Clinic’s Maryam Valapour, MD, MPP, rejoins the broadcast, along with her colleague Kenneth McCurry, MD to discuss optimization of the lung allocation system to continue reducing waitlist times and patient mortality. 

It includes commentary on how recent changes to scoring protocols are expected to impact ongoing disparities related to race and socioeconomic status. They additionally talk about the role of transplantation in patients who have severely damaged lungs resulting from COVID-19 infection, an update since our April 2021 conversation.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast